2x founder

Ananya Zutshi

Biotech/Pharma Business and Operations | Harvard MBA, MS

Co-founder

Guardian Bio· Summer 2022 🇺🇸 Boston, Massachusetts, United States

in LinkedIn

2025Co-founder· Guardian Bio

Founder · since 2021

Company

Guardian Bio

Role

Co-Founder

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Guardian Bio

Dendritic cell-based platform for cancer therapy

Summer 2022

Experience

Career

Caldera Therapeutics
Corporate Development · 2025 – Present
2025
Guardian Bio
Co-founder
Co-Founder · 2025 – Present
2025
Guardian Bio
Co-founder
Co-Founder, Business and Operations Leader / CEO · Boston, Massachusetts, United States · 2022 – 2025
2022
Harvard Business School
Founder
Blavatnik Fellow · 2021 – 2022
2021
Cellino
Entrepreneur-in-Residence · 2021 – 2022
2021
Petri
Summer Associate · 2020
2020
Catalent Pharma Solutions
Project Manager · Kansas City, Missouri Area · 2017 – 2019
2017
Catalent Pharma Solutions
Process Engineer · Somerset, New Jersey · 2016 – 2017
2016
Catalent Pharma Solutions
Business Development Technical Lead · Winchester, Kentucky · 2016
2016
Catalent Pharma Solutions
Clinical Production Supervisor · Philadelphia, Pennsylvania · 2015 – 2016
2015
Duke University
Pratt Fellow · Durham, North Carolina · 2013 – 2015
2013
Duke University
Tour Guide · 2011 – 2015
2011
All India Institute of Medical Sciences
Intern at the HLA-DNA lab · New Delhi · 2012
2012

Bio

Ananya is Co-Founder and CEO of Guardian Bio, a company which controls immunity using dendritic cell-based therapies. She has a Bachelors in Science in Engineering from Duke and Masters in Engineering and MBA from Harvard. Her experiences span across the pharma/biotech industry in operations, engineering, project management, and early stage investing. She is passionate about delivering better therapies for patients and diversity, equity, and inclusion.